Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual sufentanil for hemodynamic response during laryngoscopy
IRCT20090129001615N5Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of sufentanil (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 4 more. Started Aug 2020; status: completed.
02
Drugs
sufentanil
Beyond the preview
Go deeper on IRCT20090129001615N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090129001615N5.